News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” but so far the debates have missed the biggest threats lurking in COMPASS’s international patent applications.

Psymposia Advisory Board member Alex Zaitchik drops in to chat about his work and experiences as an investigative journalist with a critical analysis of capitalism. Alex has covered topics ranging from the effects of extractive industry on Indigenous communities, to the existential need for degrowth, and the economics of vaccine development.

Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.

My decision to attend law school was unconventional, at best.

Capitol insurrectionist Jake Angeli is a self-appointed psychedelic guru who has opined about the urgent need for psychedelic shamanism to heal the world’s biggest problems.

In order to present at Psychedelic Science 2023, speakers must agree to two out-of-the-ordinary requests about content exclusivity and MAPS’ reputation.

It’s hard to imagine Trump & Sessions stuffing the toothpaste back in the tube, but remember drug prohibition is a lucrative business.

In response to Psymposia's reporting on outgoing MAPS Canada Executive Director Mark Haden's resignation following a year full of controversies, Haden published a statement entitled “Clarifying Misinformation” that was full of misinformation and factual inaccuracies. In the following article, we set the record straight.

The Psymposia team discusses the reticence of psychedelic advocates to consider cases of unequivocal abuse and neglect of participants in MAPS clinical trials. We provide background on the gap between the public image of MAPS and the experiences shared by Meaghan, Mel, and Leah in New York Magazine's Cover Story Season 1, Power Trip.

The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."